Search results
Order by most recent / most popular / relevance
Results: 1-5 of 5
Court affirms utility of Gleevec patent
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- February 20 2013
"Sound prediction's introduction into Canadian law was not, as I understand it, to give a crushing hammer to those who challenge patents." Snider J
Impeachment action permitted to continue for expired patent to nourish subsequent damages proceeding - Apotex Inc. v. Warner-Lambert Co., 2012 FCA 323, December 5, 2012 - quinapril)
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- December 14 2012
This was an appeal from an order dismissing part of an impeachment action
Court of Appeal comment on judicial comity - Apotex Inc. v. Allergan Inc., 2012 FCA 308, November 23, 2012 - brimonidine-timop
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- December 14 2012
Justice Noël writing for the Court of Appeal disagreed with Apotex’s appeal of Justice Hughes’ decision to grant an order of prohibition with respect of the NOC for Apo-brimonidine-timop until expiry of the relevant patent
Important recent trends in pharmaceutical patent litigation
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- June 28 2011
From a patentee’s perspective, the patent litigation landscape in 2010 and continuing into 2011 appears to have shifted to a more hospitable environment for innovators
Health Canada releases 2009 statistical report on the administration of the Patented Medicines (Notice of Compliance) Regulations
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 24 2010
The Therapeutic Products Directorate recently issued its report on the administration of the Patented Medicines (Notice of Compliance) Regulations for 2009
Current Search
- Jurisdiction - Canada
- Firm Name - Gowling Lafleur Henderson LLP
- Workarea - Patents
- Author - Isabel Raasch